KAITLIN MILLER: Open Payments
NPI 1255668760 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 24 payments from 10 companies in 2025. Trend: 2023 $548 · 2024 $356 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $189 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Exact Sciences Corporation | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| JAZZ PHARMACEUTICALS INC. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| SANOFI PASTEUR INC. | 1 | $14 |
Products named: QULIPTA, VRAYLAR, UBRELVY, REXULTI, BREZTRI, Cologuard Collection Kit, REPATHA, Auvelity.
Industry payments across LA — which companies pay providers there.
